Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
NCT01364688 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2011-06-02
Summary
Active vitamin D at therapeutic dose may prevent vascular calcification but in supraphysiologic dose may precipitate it.
Conditions
- Vascular Calcification
Interventions
- DRUG
-
oral alfacalcidol
Oral alfacalcidol 0.5 microgram per day
- DRUG
-
no drug
no drug
Sponsors & Collaborators
-
Ramathibodi Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-12-31
Countries
- Thailand
More Related Trials
-
Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
NCT01528800 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Fixed Dose Versus Serum Level-Based Titration Regimen of Vitamin D Supplementation in Dialysis Patients
NCT05434377 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
NCT02999204 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D and Cardiac Autonomic Tone in Hemodialysis
NCT01774812 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D and Coronary Calcification Study
NCT00752102 ·Status: COMPLETED ·Phase: PHASE4
-
Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
NCT01237028 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Arterial Function in Patients With Chronic Kidney Disease
NCT01384539 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
NCT01561222 ·Status: UNKNOWN ·Phase: PHASE4
-
Aortic Calcification and Vitamin K Antagonists
NCT02823093 ·Status: UNKNOWN
-
Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
NCT01633853 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
NCT00294866 ·Status: COMPLETED ·Phase: PHASE4
-
Ergocalciferol in Chronic Kidney Disease
NCT00411294 ·Status: COMPLETED
-
Hemodialysis Vitamin D Pilot
NCT01214928 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
NCT01061320 ·Status: UNKNOWN ·Phase: PHASE3
-
Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients
NCT00958451 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
NCT01173848 ·Status: TERMINATED ·Phase: PHASE3
-
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
NCT00379899 ·Status: COMPLETED ·Phase: PHASE4
-
Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
NCT01312441 ·Status: TERMINATED ·Phase: PHASE4
-
Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.
NCT02895061 ·Status: COMPLETED ·Phase: NA
-
Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy
NCT03210688 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Vitamin D Supplementation on Balance in CKD
NCT03710161 ·Status: TERMINATED ·Phase: PHASE4
-
Cholecalciferol on Hemodialysis Patients
NCT03602430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease
NCT04167111 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Vitamin K 2 on Vascular Calcification in Hemodialysis Patients
NCT04145492 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Etelcalcetide on CKD-MBD
NCT03960437 ·Status: COMPLETED ·Phase: PHASE2